本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

16.17
+0.11000.68%
盤後16.170.00000.00%18:44 EDT
成交量:61.64萬
成交額:992.59萬
市值:21.61億
市盈率:-8.87
高:16.23
開:15.90
低:15.86
收:16.06
資料載入中...
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities